McKinsey MDL Judge Allows Claims Over Neonatal Abstinence Syndrome To Move Forward

(May 17, 2024, 2:25 PM EDT) -- SAN FRANCISCO — The California federal judge presiding over the McKinsey & Co. opioid promotion multidistrict litigation on May 16 partially granted and partially denied McKinsey’s motion to dismiss an amended complaint filed on behalf of minors born with neonatal abstinence syndrome (NAS)....